JP2016535270A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535270A5 JP2016535270A5 JP2016533958A JP2016533958A JP2016535270A5 JP 2016535270 A5 JP2016535270 A5 JP 2016535270A5 JP 2016533958 A JP2016533958 A JP 2016533958A JP 2016533958 A JP2016533958 A JP 2016533958A JP 2016535270 A5 JP2016535270 A5 JP 2016535270A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- proteins
- protein
- protein kinase
- kinase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004169 proteins and genes Human genes 0.000 claims 49
- 108090000623 proteins and genes Proteins 0.000 claims 49
- 206010028980 Neoplasm Diseases 0.000 claims 37
- 239000000090 biomarker Substances 0.000 claims 18
- 238000000034 method Methods 0.000 claims 17
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 16
- 201000002528 pancreatic cancer Diseases 0.000 claims 16
- 239000000523 sample Substances 0.000 claims 14
- 102100035044 Myosin light chain kinase, smooth muscle Human genes 0.000 claims 13
- 102100032822 Homeodomain-interacting protein kinase 1 Human genes 0.000 claims 11
- 101710110794 Homeodomain-interacting protein kinase 1 Proteins 0.000 claims 11
- 230000009822 protein phosphorylation Effects 0.000 claims 11
- 229940079593 drug Drugs 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 108010074596 Myosin-Light-Chain Kinase Proteins 0.000 claims 7
- 108010001441 Phosphopeptides Proteins 0.000 claims 7
- 102100025352 Serine/threonine-protein kinase MRCK alpha Human genes 0.000 claims 7
- 101710112530 Serine/threonine-protein kinase MRCK alpha Proteins 0.000 claims 7
- 230000035945 sensitivity Effects 0.000 claims 7
- 101001022780 Homo sapiens Myosin light chain kinase, smooth muscle Proteins 0.000 claims 6
- 102100024193 Mitogen-activated protein kinase 1 Human genes 0.000 claims 6
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 6
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 6
- 230000001394 metastastic effect Effects 0.000 claims 5
- 206010061289 metastatic neoplasm Diseases 0.000 claims 5
- 108700015928 Mitogen-activated protein kinase 13 Proteins 0.000 claims 4
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- 230000026731 phosphorylation Effects 0.000 claims 4
- 238000006366 phosphorylation reaction Methods 0.000 claims 4
- 102000004196 processed proteins & peptides Human genes 0.000 claims 4
- 101001031598 Dictyostelium discoideum Probable serine/threonine-protein kinase fhkC Proteins 0.000 claims 3
- 230000027455 binding Effects 0.000 claims 3
- 239000007853 buffer solution Substances 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 210000004923 pancreatic tissue Anatomy 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 230000009870 specific binding Effects 0.000 claims 3
- 238000005406 washing Methods 0.000 claims 3
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 claims 2
- 102000012334 Integrin beta4 Human genes 0.000 claims 2
- 108010022238 Integrin beta4 Proteins 0.000 claims 2
- 108700027649 Mitogen-Activated Protein Kinase 3 Proteins 0.000 claims 2
- 102100024192 Mitogen-activated protein kinase 3 Human genes 0.000 claims 2
- 101710113459 RAC-alpha serine/threonine-protein kinase Proteins 0.000 claims 2
- 102100035221 Tyrosine-protein kinase Fyn Human genes 0.000 claims 2
- 101710102899 Tyrosine-protein kinase Fyn Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 239000012472 biological sample Substances 0.000 claims 2
- 230000007423 decrease Effects 0.000 claims 2
- 230000029087 digestion Effects 0.000 claims 2
- 230000003828 downregulation Effects 0.000 claims 2
- 230000003827 upregulation Effects 0.000 claims 2
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 claims 1
- 108010069682 CSK Tyrosine-Protein Kinase Proteins 0.000 claims 1
- 102100028003 Catenin alpha-1 Human genes 0.000 claims 1
- 101710106615 Catenin alpha-1 Proteins 0.000 claims 1
- ZBNZXTGUTAYRHI-UHFFFAOYSA-N Dasatinib Chemical compound C=1C(N2CCN(CCO)CC2)=NC(C)=NC=1NC(S1)=NC=C1C(=O)NC1=C(C)C=CC=C1Cl ZBNZXTGUTAYRHI-UHFFFAOYSA-N 0.000 claims 1
- 101000876610 Dictyostelium discoideum Extracellular signal-regulated kinase 2 Proteins 0.000 claims 1
- 102100022975 Glycogen synthase kinase-3 alpha Human genes 0.000 claims 1
- 102000015616 Histone Deacetylase 1 Human genes 0.000 claims 1
- 108010024124 Histone Deacetylase 1 Proteins 0.000 claims 1
- 108010023981 Histone Deacetylase 2 Proteins 0.000 claims 1
- 102100039999 Histone deacetylase 2 Human genes 0.000 claims 1
- 102000009331 Homeodomain Proteins Human genes 0.000 claims 1
- 108010048671 Homeodomain Proteins Proteins 0.000 claims 1
- 101001052493 Homo sapiens Mitogen-activated protein kinase 1 Proteins 0.000 claims 1
- 101100087590 Homo sapiens RICTOR gene Proteins 0.000 claims 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 102000014748 Junctional Adhesion Molecules Human genes 0.000 claims 1
- 108010064064 Junctional Adhesion Molecules Proteins 0.000 claims 1
- 239000005511 L01XE05 - Sorafenib Substances 0.000 claims 1
- 239000002067 L01XE06 - Dasatinib Substances 0.000 claims 1
- 101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 claims 1
- 108040008097 MAP kinase activity proteins Proteins 0.000 claims 1
- 102000019149 MAP kinase activity proteins Human genes 0.000 claims 1
- 102000043136 MAP kinase family Human genes 0.000 claims 1
- 108091054455 MAP kinase family Proteins 0.000 claims 1
- 101710166115 Mitogen-activated protein kinase 2 Proteins 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 108010008707 Mucin-1 Proteins 0.000 claims 1
- 102000003505 Myosin Human genes 0.000 claims 1
- 108060008487 Myosin Proteins 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 108010029869 Proto-Oncogene Proteins c-raf Proteins 0.000 claims 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 claims 1
- 102000046941 Rapamycin-Insensitive Companion of mTOR Human genes 0.000 claims 1
- 108700019586 Rapamycin-Insensitive Companion of mTOR Proteins 0.000 claims 1
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 claims 1
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 claims 1
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 229960002448 dasatinib Drugs 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108010049611 glycogen synthase kinase 3 alpha Proteins 0.000 claims 1
- 238000004949 mass spectrometry Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- AXTAPYRUEKNRBA-JTQLQIEISA-N n-[(2s)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide Chemical compound CN1N=CC(Cl)=C1C1=C(Cl)OC(C(=O)N[C@H](CN)CC=2C=C(F)C(F)=CC=2)=C1 AXTAPYRUEKNRBA-JTQLQIEISA-N 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 239000012474 protein marker Substances 0.000 claims 1
- 208000011581 secondary neoplasm Diseases 0.000 claims 1
- 210000002460 smooth muscle Anatomy 0.000 claims 1
- 229960003787 sorafenib Drugs 0.000 claims 1
- 229960000235 temsirolimus Drugs 0.000 claims 1
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
- WAEXFXRVDQXREF-UHFFFAOYSA-N vorinostat Chemical compound ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1 WAEXFXRVDQXREF-UHFFFAOYSA-N 0.000 claims 1
- 229960000237 vorinostat Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1314485.2 | 2013-08-13 | ||
| GBGB1314485.2A GB201314485D0 (en) | 2013-08-13 | 2013-08-13 | Materials and methods relating to pancreatic cancer |
| PCT/GB2014/052475 WO2015022530A2 (en) | 2013-08-13 | 2014-08-13 | Materials and methods relating to pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016535270A JP2016535270A (ja) | 2016-11-10 |
| JP2016535270A5 true JP2016535270A5 (enExample) | 2017-12-28 |
Family
ID=49262110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016533958A Pending JP2016535270A (ja) | 2013-08-13 | 2014-08-13 | 膵臓癌に関連する物質及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160195536A1 (enExample) |
| EP (1) | EP3033624A2 (enExample) |
| JP (1) | JP2016535270A (enExample) |
| CN (1) | CN105637367A (enExample) |
| CA (1) | CA2920946A1 (enExample) |
| GB (1) | GB201314485D0 (enExample) |
| WO (1) | WO2015022530A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017044715A1 (en) * | 2015-09-09 | 2017-03-16 | Somalogic, Inc. | Methods for developing personalized drug treatment plans and targeted drug development based on proteomic profiles |
| US10617720B2 (en) * | 2016-10-20 | 2020-04-14 | Miltenyi Biotech, GmbH | Chimeric antigen receptor specific for tumor cells |
| BR112019012441A2 (pt) * | 2016-12-20 | 2020-04-14 | Treat4Life Ab | método para determinar mutações braf e proteína braf do tipo selvagem por espectrometria de massa |
| EP3811081A1 (en) * | 2018-06-21 | 2021-04-28 | Universiteit Utrecht Holding B.V. | Method for monitoring kinase activity in a sample |
| CN111066727B (zh) * | 2019-12-20 | 2021-08-27 | 中国人民解放军陆军军医大学 | 在低氧性血睾屏障通透中作用机制的小鼠模型构建方法 |
| IT202000016807A1 (it) * | 2020-07-10 | 2022-01-10 | Humanitas Mirasole Spa | Peptidi associati a tumore e loro impiego |
| WO2022154037A1 (ja) * | 2021-01-14 | 2022-07-21 | 公立大学法人福島県立医科大学 | がんの予後バイオマーカー |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR970002255B1 (ko) | 1990-06-11 | 1997-02-26 | 넥스스타 파아마슈티컬드, 인크. | 핵산 리간드 |
| US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
| ATE508361T1 (de) | 2001-08-14 | 2011-05-15 | Harvard College | Absolute quantifizierung von proteinen und modifizierten formen davon mittels mehrstufiger massenspektrometrie |
| US20040219572A1 (en) * | 2002-12-17 | 2004-11-04 | Jie Chen | Specific markers for pancreatic cancer |
| CN1726395A (zh) * | 2002-12-17 | 2006-01-25 | 北京诺赛基因组研究中心有限公司 | 胰腺癌的特异标记 |
| US8346482B2 (en) * | 2003-08-22 | 2013-01-01 | Fernandez Dennis S | Integrated biosensor and simulation system for diagnosis and therapy |
| DE102006056784A1 (de) * | 2006-12-01 | 2008-06-05 | Meyer, Helmut E., Prof.Dr. | Biomarker für die Diagnose von Pankreaskrebs |
| GB0704764D0 (en) | 2007-03-12 | 2007-04-18 | Electrophoretics Ltd | Isobarically labelled reagents and methods of their use |
| US20110224313A1 (en) * | 2008-06-05 | 2011-09-15 | British Columbia Cancer Agency Branch | Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| CA2750818A1 (en) * | 2009-01-27 | 2010-08-05 | Proteogenix, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| WO2011088030A1 (en) * | 2010-01-15 | 2011-07-21 | Bryan William Jones | Disease diagnosis and treatment using computational molecular phenotyping |
| TW201130830A (en) * | 2010-02-01 | 2011-09-16 | Ab Science | Combined treatment of pancreatic cancer with gemcitabine and masitinib |
| AU2011242990B2 (en) * | 2010-04-19 | 2015-02-12 | Biomarker Strategies, Llc. | Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
| AU2011260390B2 (en) * | 2010-06-01 | 2016-11-24 | Ernst-Moritz-Arndt Universitat Greifswald | Means and methods for diagnosing pancreatic cancer in a subject |
| ES2611479T3 (es) * | 2010-06-16 | 2017-05-09 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Anticuerpos contra endoplasmina y su uso |
| CA2838736A1 (en) * | 2011-06-07 | 2012-12-13 | Caris Mpi, Inc. | Molecular profiling for cancer |
-
2013
- 2013-08-13 GB GBGB1314485.2A patent/GB201314485D0/en not_active Ceased
-
2014
- 2014-08-13 CA CA2920946A patent/CA2920946A1/en not_active Abandoned
- 2014-08-13 EP EP14755897.7A patent/EP3033624A2/en not_active Withdrawn
- 2014-08-13 CN CN201480056359.9A patent/CN105637367A/zh active Pending
- 2014-08-13 US US14/912,299 patent/US20160195536A1/en not_active Abandoned
- 2014-08-13 WO PCT/GB2014/052475 patent/WO2015022530A2/en not_active Ceased
- 2014-08-13 JP JP2016533958A patent/JP2016535270A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220214344A1 (en) | Method, array and use thereof | |
| Chen et al. | Prognostic fifteen-gene signature for early stage pancreatic ductal adenocarcinoma | |
| Leligdowicz et al. | Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection | |
| CN106662578B (zh) | 用于检测食物变态反应的肽、试剂和方法 | |
| CA2974775C (en) | Biomarkers for pancreatic cancer | |
| KR102289278B1 (ko) | 췌장암 진단용 바이오마커 패널 및 그 용도 | |
| Cao et al. | Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts | |
| KR20140040118A (ko) | 췌장암의 존재를 결정하기 위한 방법, 어레이 및 그의 용도 | |
| JP2010522875A5 (enExample) | ||
| JP2016511406A (ja) | アルツハイマー病の診断のための方法と組成物 | |
| JP6104796B2 (ja) | 方法、アレイ、およびこれらの使用 | |
| JP2016536568A5 (enExample) | ||
| Zhang et al. | Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ‐Based Quantitative Proteomic Analysis | |
| JP2016535270A (ja) | 膵臓癌に関連する物質及び方法 | |
| AU2014247083A1 (en) | Methods and arrays for use in biomarker detection for prostate cancer | |
| JP2016519767A5 (enExample) | ||
| Park et al. | Evolutionary identification of affinity peptides for the detection of sepsis biomarker procalcitonin | |
| Zhou et al. | Oncoproteomics: trials and tribulations | |
| EP4314347A1 (en) | Proteogenomic analysis of non-small cell lung cancer | |
| Panis et al. | How can proteomics reach cancer biomarkers? | |
| Chao et al. | Towards proteome standards: the use of absolute quantitation in high-throughput biomarker discovery | |
| KR102131860B1 (ko) | 아르기닌이 메틸화된 ggt1에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물 | |
| US20210080465A1 (en) | SH2 domain-based prognostic biomarker for chronic lymphocytic leukemia | |
| Jin et al. | Antibody microarrays for high-throughput, multianalyte analysis | |
| Jeon et al. | C-reactive protein as a parameter for defining normal blood samples in identification and evaluation of serological biomarkers |